The EU Commission sends statements of objections to more than a dozen companies in connection with investigations in the pharmaceutical sector (Citalopram)

European Commission issues Statements of Objections against several pharmaceutical companies* On 25 and 30 July 2012, in relation to the Citalopram case and the Perindopril case respectively, the European Commission sent statements of objections (“SOs”) to more than a dozen companies in connection with these two antitrust investigations in the pharmaceutical sector. The Commission also issued a note highlighting its current enforcement action in pharmaceutical sector following its inquiry. In the Perindopril case, the SO was sent

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Gabriele Accardo, The EU Commission sends statements of objections to more than a dozen companies in connection with investigations in the pharmaceutical sector (Citalopram), 25 July 2012, e-Competitions Bulletin July 2012, Art. N° 58429

Visites 101

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues